Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Comment by joe_trouton Dec 01, 2010 8:25pm

252 Views

Post# 17786841

RE: Time to move on...................

That's interesting. I see value here. Cheap price, lots of value. I am camping out on this one. Maybe it takes a few years, and maybe it doesn't. It's just one of many that I own. Some of my stocks are under performing and some are over performing, but the overall trend is way up.

NOX may very likely be over performing when my high flyers are under performing. It's just the way the market works. Bottom line, I see a lot of value here and I expect it to be recognized sooner or later.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments